0001209191-22-005659.txt : 20220131
0001209191-22-005659.hdr.sgml : 20220131
20220131171632
ACCESSION NUMBER: 0001209191-22-005659
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220127
FILED AS OF DATE: 20220131
DATE AS OF CHANGE: 20220131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lavelle Erin
CENTRAL INDEX KEY: 0001737613
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40708
FILM NUMBER: 22575063
MAIL ADDRESS:
STREET 1: C/O ALDER BIOPHARMACEUTICALS, INC.
STREET 2: 11804 NORTH CREEK PARKWAY SOUTH
CITY: BOTHELL
STATE: WA
ZIP: 98011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
BUSINESS PHONE: 425-276-2300
MAIL ADDRESS:
STREET 1: 23515 NE NOVELTY HILL ROAD
STREET 2: SUITE B221 #125
CITY: REDMOND
STATE: WA
ZIP: 98053
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-27
0
0001768446
Eliem Therapeutics, Inc.
ELYM
0001737613
Lavelle Erin
C/O ELIEM THERAPEUTICS, INC.
23515 NE NOVELTY HILL RD, STE. B221 #125
REDMOND
WA
98053
0
1
0
0
COO & CFO
Stock Option (Right to Buy)
8.21
2022-01-27
4
A
0
170000
0.00
A
2032-01-26
Common Stock
170000
170000
D
For so long as the Reporting Person continuously provides services to the Issuer, this option will vest with respect to the shares as follows: 1/48th of the shares will vest on each monthly anniversary of January 27, 2022.
/s/ Alan Hambelton, Attorney-in-Fact
2022-01-31